Dah Chong Hong will join forces with parent company Citic Pacific to form an $80m healthcare and consumer-focused vehicle dubbed Tamar Alliance Fund.

Quest Diagnostics will acquire Cleveland HeartLab, a cardiac diagnostics test provider spun out of Cleveland Clinic, or an undisclosed sum.

AstraZeneca has returned to back a $200m private placement for cancer drug developer ADC Therapeutics, which has now raised a total of $455m.

The hearing aid developer has raised $32.4m from investors including Nan Fung Life Sciences for the first close of its series C round.

Infectious and respiratory disease drug developer Vir Biotechnology said it has now raised more than $500m from investors such as SoftBank Vision Fund.

Returning investor GV took part in a Wellington Management-led series B round that will support assessment of its lead oncology drug candidate.

The genetic testing service, spun out from City University of Hong Kong, took its total funding to approximately $53m with a round co-led by Alibaba and Beyond Ventures.

The Johns Hopkins spinout has passed a clinical milestone to trigger the final part of a series B round backed by Osage University Partners.

Stanford spinout Forty Seven is working on an immuno-oncology treatment to fight the overproduction of proteins which inhibit the immune response to cancer.